Cargando…

A SARS-CoV-2 nanobody that can bind to the RBD region may be used for treatment in COVID-19 in animals

Coronavirus disease 2019 (COVID-19) caused by an infectious virus, severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), poses a threat to the world. The suitable treatments must be identified for this disease in animals. Nanobody have therapeutic potential in the COVID-19. In this study, SA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Peng, Yang, Qin, Zhao, Xiaoli, Liu, Qingqing, Xi, Jing, Zhang, Fan, He, Jinke, Yang, Hang, Zhang, Chao, Ma, Zhongchen, Deng, Xiaoyu, Wang, Yong, Chen, Chuangfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821020/ https://www.ncbi.nlm.nih.gov/pubmed/35152188 http://dx.doi.org/10.1016/j.rvsc.2022.02.003

Ejemplares similares

Characterizing Binding Kinetics and Thermodynamics of Computer-Designed Nanobodies Targeting SARS-CoV-2 RBD
por: Ferraz, Matheus, et al.
Publicado: (2021)

Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies
por: Kaewchim, Kanasap, et al.
Publicado: (2023)

An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
por: Chi, Xiaojing, et al.
Publicado: (2022)

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
por: Lu, Qizhong, et al.
Publicado: (2021)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiangdong, et al.
Publicado: (2020)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
por: Huo, Jiandong, et al.
Publicado: (2021)

A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection
por: Li, Tingting, et al.
Publicado: (2021)

Interferon-Inducible Transmembrane Protein 3-Containing Exosome as a New Carrier for the Cell-to-Cell Transmission of Anti-Brucella Activity
por: Yi, Jihai, et al.
Publicado: (2021)

A Competitive Panning Method Reveals an Anti-SARS-CoV-2 Nanobody Specific for an RBD-ACE2 Binding Site
por: He, Siqi, et al.
Publicado: (2023)

Small ubiquitin-related modifier 2 affects the intracellular survival of Brucella abortus 2308 by regulating activation of the NF-κB pathway
por: Wang, Yueli, et al.
Publicado: (2020)

Scanning iron response regulator binding sites using Dap-seq in the Brucella genome
por: Zhang, Huan, et al.
Publicado: (2023)

Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection
por: Li, Tingting, et al.
Publicado: (2022)

E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies
por: Wang, Wei Bu, et al.
Publicado: (2021)

Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies
por: Zuo, Jing, et al.
Publicado: (2017)

A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2
por: Yao, Hebang, et al.
Publicado: (2021)

Structures of synthetic nanobody–SARS-CoV-2–RBD complexes reveal distinct sites of interaction and recognition of variants
por: Ahmad, Javeed, et al.
Publicado: (2021)

Correction: Kaewchim et al. Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies. Viruses 2023, 15, 1252
por: Kaewchim, Kanasap, et al.
Publicado: (2023)

A Novel Nanobody Directed against Ovine Myostatin to Enhance Muscle Growth in Mouse
por: Ou, Kepeng, et al.
Publicado: (2020)

Selection and characterization of specific nanobody against bovine virus diarrhea virus (BVDV) E2 protein
por: Li, Tiansen, et al.
Publicado: (2017)

A Novel Fusion Protein System for the Production of Nanobodies and the SARS-CoV-2 Spike RBD in a Bacterial System
por: Nagy-Fazekas, Dóra, et al.
Publicado: (2023)

Low-Entropy Hydration Shells at the Spike RBD’s Binding Site May Reveal the Contagiousness of SARS-CoV-2 Variants
por: Yang, Lin, et al.
Publicado: (2023)

Brucella abortus BspJ Is a Nucleomodulin That Inhibits Macrophage Apoptosis and Promotes Intracellular Survival of Brucella
por: Ma, Zhongchen, et al.
Publicado: (2020)

LDH as an adjuvant makes Brucella outer-membrane vesicles and outer-membrane vesicle-associated proteins highly protective in mice
por: Deng, Xiaoyu, et al.
Publicado: (2023)

Construction of a T7 phage display nanobody library for bio-panning and identification of chicken dendritic cell-specific binding nanobodies
por: Xu, Hai, et al.
Publicado: (2022)

Nanobody-Based Indirect Competitive ELISA for Sensitive Detection of 19-Nortestosterone in Animal Urine
por: Yang, Yuan-yuan, et al.
Publicado: (2021)

Entropic contribution of ACE2 glycans to RBD binding
por: Mugnai, Mauro L., et al.
Publicado: (2023)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

Exosomes released by Brucella‐infected macrophages inhibit the intracellular survival of Brucella by promoting the polarization of M1 macrophages
por: Wang, Yueli, et al.
Publicado: (2023)

A Targeted Catalytic Nanobody (T-CAN) with Asparaginolytic Activity
por: Maggi, Maristella, et al.
Publicado: (2021)

The Recombinant Expression Proteins FnBP and ClfA From Staphylococcus aureus in Addition to GapC and Sip From Streptococcus agalactiae Can Protect BALB/c Mice From Bacterial Infection
por: Ma, Zhongchen, et al.
Publicado: (2021)

Recombinant expression of nanobodies and nanobody-derived immunoreagents
por: de Marco, Ario
Publicado: (2020)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Targeting Ras-binding domain of ELMO1 by computational nanobody design
por: Tam, Chunlai, et al.
Publicado: (2023)

Mutational escape prevention by combination of four neutralizing antibodies that target RBD conserved regions and stem helix
por: Tang, Haoneng, et al.
Publicado: (2022)

Optogenetic control of protein binding using light-switchable nanobodies
por: Gil, Agnieszka A., et al.
Publicado: (2020)

Structural Insights into the Binding of Red Fluorescent Protein mCherry-Specific Nanobodies
por: Liang, Hui, et al.
Publicado: (2023)

A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding
por: Yang, Jing, et al.
Publicado: (2022)

Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding
por: Yang, Li Jun, et al.
Publicado: (2021)

Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal models
por: Cohen, Alexander A., et al.
Publicado: (2022)

Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
por: Cohen, Alexander A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gcahos9oqekvvuufpgqv14kdn1